Nicholson G M, Spence I, Johnston G A
Department of Applied Biology, N.S.W. Institute of Technology, Sydney, Australia.
Neuropharmacology. 1988 May;27(5):459-65. doi: 10.1016/0028-3908(88)90127-x.
The effects of various pairs of convulsant and nonconvulsant barbiturates on mono- and polysynaptic activity were studied in the isolated spinal cord of the immature rat, using extracellular recording. The convulsant barbiturates, 5-ethyl-5-(3-methylbut-2'-enyl) barbituric acid (3M2B), 5-ethyl-5-(1,3-dimethylbut-1'-enyl) barbituric acid (1,3M1B) and (+)-5-(1,3-dimethylbutyl)-5-ethyl barbituric acid [(+) DMBB] all increased the monosynaptic reflex at concentrations between 5 and 50 microM with no change in polysynaptic activity. When the concentration was raised to between 100 and 300 microM, however, the convulsants all reduced the monosynaptic reflex, thus producing a biphasic dose-response relationship. The nonconvulsant barbiturates phenobarbital, 5-ethyl-5-(3-methylbut-1'-enyl) barbituric acid (3M1B), amylobarbital (3MB) and (-)-5-(1,3-dimethylbutyl)-5-ethyl barbituric acid [(-)DMBB] produced only a decrease in mono- and polysynaptic reflexes. At concentrations which enhanced the monosynaptic reflex, the responses of motoneurones to glycine and eledoisin-related peptide (an analogue of substance P) were reduced by (+)DMBB, while 1,3M1B and 3M2B had no significant effects upon any of the neurotransmitters tested. At concentrations which depressed the monosynaptic reflex, the convulsants all reduced the response to glycine whereas the nonconvulsant barbiturates all increased the response to GABA. With the exception of phenobarbital, both convulsant and nonconvulsant barbiturates produced a direct depolarisation of the presynaptic terminal membrane, with only the convulsants producing a depolarisation of the membrane of the motoneurone. Using another convulsant barbiturate, 5-(2-cyclohexylideneethyl)-5-ethyl barbituric acid (CHEB), this direct depolarising action was found to be calcium-dependent.
利用细胞外记录技术,研究了多种惊厥性和非惊厥性巴比妥类药物对未成熟大鼠离体脊髓单突触和多突触活动的影响。惊厥性巴比妥类药物,5-乙基-5-(3-甲基丁-2'-烯基)巴比妥酸(3M2B)、5-乙基-5-(1,3-二甲基丁-1'-烯基)巴比妥酸(1,3M1B)和(+)-5-(1,3-二甲基丁基)-5-乙基巴比妥酸[(+)DMBB],在5至50微摩尔浓度之间均增加单突触反射,而多突触活动无变化。然而,当浓度提高到100至300微摩尔之间时,惊厥性药物均降低单突触反射,从而产生双相剂量反应关系。非惊厥性巴比妥类药物苯巴比妥、5-乙基-5-(3-甲基丁-1'-烯基)巴比妥酸(3M1B)、戊巴比妥(3MB)和(-)-5-(1,3-二甲基丁基)-5-乙基巴比妥酸[(-)DMBB]仅使单突触和多突触反射降低。在增强单突触反射的浓度下,(+)DMBB降低运动神经元对甘氨酸和伊氏缩胆囊肽(一种P物质类似物)的反应,而1,3M1B和3M2B对所测试的任何神经递质均无显著影响。在降低单突触反射的浓度下,惊厥性药物均降低对甘氨酸的反应,而非惊厥性巴比妥类药物均增加对GABA的反应。除苯巴比妥外,惊厥性和非惊厥性巴比妥类药物均使突触前终末膜直接去极化,只有惊厥性药物使运动神经元膜去极化。使用另一种惊厥性巴比妥类药物5-(2-环己叉乙基)-5-乙基巴比妥酸(CHEB),发现这种直接去极化作用是钙依赖性的。